Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease [NA]
A clinical trial is evaluating whether the CMNT Diet, by targeting liver fat, can improve treatment outcomes for people with type 2 diabetes…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly [NA]
A clinical study comparing Gepaktiv to ursodeoxycholic acid (UDCA) and ademetionine in metabolic dysfunction-associated fatty liver disease …
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity [NA]
Recruiting for a study on macrophage lysosomal lipid metabolism in obesity, exploring mechanisms that may influence obesity and related live…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease [Phase 4]
This is a Phase 4 clinical trial evaluating whether anti-osteoporotic medications affect nonalcoholic fatty liver disease. The study is curr…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Digital Early Warning System for Acute Lung Injury in Liver Surgery
A ClinicalTrials.gov entry describing a study of a digital early warning system to detect acute lung injury in patients undergoing liver sur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
A prospective cohort and biobank study on nonalcoholic fatty liver disease and related steatohepatitis (NAFLD/MASH/NASH) is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Exploratory clinical trial evaluating the Enhanced Liver Function (ELF) test to detect early fatty liver in a high-risk population; currentl…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients [NA]
A recruiting trial evaluating the accuracy of imaging techniques for diagnosing non-alcoholic steatohepatitis and fibrosis in patients with …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes [NA]
A clinical trial is investigating whether bempedoic acid can affect liver fat in individuals with nonalcoholic fatty liver disease and type …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM). [Phase 1, Phase 2]
Status update on a Phase 1/Phase 2 trial evaluating dapagliflozin in patients with type 2 diabetes mellitus and nonalcoholic fatty liver dis…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
Clinical trial update describing microbiome characterization in the peritoneum, jejunum, rectum, and stool among participants with obesity a…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents [NA]
ClinicalTrials.gov entry notes a study evaluating a moderately carbohydrate-restricted diet to treat nonalcoholic fatty liver disease and ob…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD. [NA]
A clinical trial update indicates an ongoing, invitation-only study evaluating the impact of pedometer-motivated physical activity on MASLD …
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Hepatic Elastography-Enhanced Lifestyle Modification in MASLD [NA]
Ongoing clinical trial update shows enrollment by invitation for a hepatic elastography-enhanced lifestyle modification program in MASLD pat…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions [NA]
Clinical trial update describing a study that integrates metabolic and vascular sensors to monitor cardiometabolic disorders after nutrition…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Hepatoprotective Measures for Children at High Risk of NAFLD [Phase 4]
Phase 4 clinical trial update on hepatoprotective measures for children at high risk of nonalcoholic fatty liver disease, including those wh…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
A clinical trial update on a cell-based therapy using C-Kit positive hepatic endothelial cells with MerTK deficiency for nonalcoholic fatty …
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
This clinical trial update reviews the validity of laboratory biomarkers for diagnosing nonalcoholic fatty liver disease. It discusses poten…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD [Phase 2]
Phase 2a clinical trial update evaluating the safety, tolerability, and efficacy of TLC-2716 in adults with hypertriglyceridemia and nonalco…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Longitudinal Observational Study Of Chinese With NAFLD/NASH
A longitudinal observational study enrolling Chinese participants with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis is c…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
This is an ongoing clinical trial follow-up study investigating Chronic hepatitis B patients with comorbid Nonalcoholic fatty liver disease,…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD [Phase 4]
Phase 4 clinical trial investigating the effect of erugliflozin on liver fat, liver fibrosis, and glycemic control in patients with type 2 d…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease [NA]
This ClinicalTrials.gov entry describes a study aimed at optimizing noninvasive assessment of dysmetabolic compensated advanced liver diseas…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
This clinical trial update notes ongoing recruitment for a study evaluating quantitative ultrasound methods to diagnose nonalcoholic steatoh…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
This clinical trial update describes a study on digital prevention strategies for nonalcoholic fatty liver disease and nonalcoholic steatohe…